Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/15/1992 | WO1992008465A3 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
10/15/1992 | WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
10/15/1992 | WO1992007566A3 Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues |
10/15/1992 | DE4111861A1 Benzopyranone, verfahren zu ihrer herstellung und verwendung Benzopyranones, processes for their preparation and use |
10/15/1992 | DE4111679A1 Neue cytarabin-derivate, ihre herstellung und verwendung New cytarabine derivatives, their production and use |
10/15/1992 | CA2108009A1 Method for assaying ionized magnesium and calcium concentrations and a composition of bioavailable magnesium and calcium |
10/15/1992 | CA2107892A1 Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof |
10/15/1992 | CA2107789A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences |
10/15/1992 | CA2107371A1 Method of inhibiting fibrosis |
10/15/1992 | CA2104794A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
10/15/1992 | CA2083842A1 Method for preparation of an aqueous suspension |
10/15/1992 | CA2083825A1 Novel taurine-based pharmaceutical composition for administration by inhalation |
10/14/1992 | WO1992018130A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection |
10/14/1992 | EP0508969A1 Process for conditioning of water-soluble substances |
10/14/1992 | EP0508955A1 Use of 2-iminothiazolidin-4-one derivatives as new medicaments |
10/14/1992 | EP0508901A2 Alpha-methylene-4-[(phenoxy)methyl)]5-thiazolacetic acid derivatives, process for their preparation, intermediates in this process, their use as fungicides and compositions containing them |
10/14/1992 | EP0508900A1 New steroid derivatives of Pregna-1,4-dien-3,20-dione, their preparation and use in the preparation of substituted 16,17-methylenedioxy derivatives and new intermediates |
10/14/1992 | EP0508842A1 Aminoacylphenol derivatives, process for their preparation and pharmaceutical compositions containing them |
10/14/1992 | EP0508799A1 Cholecystokinin antagonists |
10/14/1992 | EP0508798A1 Cholecystokinin antagonists |
10/14/1992 | EP0508797A1 Cholecystokinin antagonists |
10/14/1992 | EP0508796A1 Cholecystokinin antagonists |
10/14/1992 | EP0508795A1 8a-aza-8a-homoerythromycin cyclic iminoethers |
10/14/1992 | EP0508792A1 Anti-tumor and anti-psoriatic agents |
10/14/1992 | EP0508756A1 Stabilized vitamin D preparation |
10/14/1992 | EP0508740A1 Thiazolidinedione derivatives, their production and their use |
10/14/1992 | EP0508726A1 Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives |
10/14/1992 | EP0508725A1 Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers |
10/14/1992 | EP0508724A1 Radiopharmaceutical bacteriostats |
10/14/1992 | EP0508723A1 Angiotensin II antagonists incorporating an indole or dihydroindole |
10/14/1992 | EP0508699A1 9-Deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and 8a-positions |
10/14/1992 | EP0508690A1 Tetronic and thiotetronic acid derivatives |
10/14/1992 | EP0508687A1 ATP analogues |
10/14/1992 | EP0508682A1 Antibiotic carbapenem derivatives |
10/14/1992 | EP0508665A2 Use of ACE inhibitors for lowering serum cholesterol |
10/14/1992 | EP0508586A1 Substituted indenyl compounds |
10/14/1992 | EP0508549A2 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia |
10/14/1992 | EP0508524A1 Use of zinc ions for the treatment of periodontitis |
10/14/1992 | EP0508511A1 Compositions containing verapamil and trandolapril |
10/14/1992 | EP0508488A2 Use of inositol triphosphate for the treatment of diseases associated with metal intoxications |
10/14/1992 | EP0508445A1 1-Arylheteroarylalkyl substituted-1H-1,2,4-triazole compounds for treatment of circulatory disorders |
10/14/1992 | EP0508425A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase |
10/14/1992 | EP0508393A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
10/14/1992 | EP0508375A2 Novel cephalosporin compounds and processes for preparation thereof |
10/14/1992 | EP0508370A1 Condensed diazepinones, process for their preparation and compositions containing them for the treatment of the central nervous system and to enhance cerebral perfusion |
10/14/1992 | EP0508347A1 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use |
10/14/1992 | EP0508334A2 Novel aminophenol derivatives and pharmaceutical compositions thereof |
10/14/1992 | EP0508324A2 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging |
10/14/1992 | EP0508312A1 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts |
10/14/1992 | EP0508311A1 Injectable compositions containing 2-oxindole-1-carboxamide derivatives |
10/14/1992 | EP0508310A1 Pharmaceutical composition for rectal administration, which contains a 2-oxindole-1-carboxamide derivative |
10/14/1992 | EP0508234A2 Beta-lactames |
10/14/1992 | EP0508220A1 Derivatives of amindinophenylalanine, procedure for their preparation, their utilisation and compositions comprising them |
10/14/1992 | EP0507944A1 Implantable biodegradable material and method for producing same. |
10/14/1992 | EP0507938A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
10/14/1992 | EP0507921A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic |
10/14/1992 | EP0507914A1 PROCESS FOR THE PREPARATION OF 1$g(b)-ETHYL-1$g(a)-(HYDROXYMETHYL)-1,2,3,4,6,7,12,12b$g(a)-OCTAHYDRO-INDOLO 2,3-a]QUINOLIZINE AND NOVEL INTERMEDIATES |
10/14/1992 | EP0507872A1 The use of arginine as an immunostimulator |
10/14/1992 | EP0507870A1 Polyhemoglobin stabilized by purine derivatives and glutathione. |
10/14/1992 | EP0507863A1 Sigma receptor ligands and the use thereof |
10/14/1992 | EP0500802A4 Liposomal compositions |
10/14/1992 | EP0403575B1 Acyl carnitine for the treatment and prevention of virus infections |
10/14/1992 | EP0380501B1 Glycosaminoglycan for the treatment of diabetic microangiopathy |
10/14/1992 | EP0368933B1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
10/14/1992 | EP0303681B1 Immunosuppression in immunotoxin based human therapy |
10/14/1992 | CN1065274A Platinum complex and processes for preparing same |
10/14/1992 | CN1065270A Process for preparation of enantiomerically pure thienopyran derivatives |
10/14/1992 | CN1065269A Pyridazinone acetic acids |
10/14/1992 | CN1065267A Heterocyclic-cyclic amine derivatives |
10/14/1992 | CN1065265A Optically active aminoketone derivative and method for preparing same |
10/14/1992 | CN1065264A Stereoselective preparation of substituted piperidines |
10/14/1992 | CN1065205A Preventive agent against infectious disease of crustacea |
10/14/1992 | CN1065203A Preparation of alkalizing local narcotic |
10/14/1992 | CN1018649B Immunoglobulin conjugates |
10/14/1992 | CN1018648B Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives |
10/14/1992 | CN1018646B Process for preparing glycoside |
10/14/1992 | CN1018644B Oxadiazole-alkyl-purine derivatives |
10/14/1992 | CN1018642B Mfg. method for pyridine derivatives |
10/14/1992 | CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines |
10/14/1992 | CN1018614B Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
10/14/1992 | CA2108175A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection |
10/13/1992 | WO1992018500A1 Isoxazolyl imidazole derivatives, process for producing them and their use in medicaments |
10/13/1992 | WO1992018125A1 Michellamines useful as antiviral agents, composition and method of treatment |
10/13/1992 | US5155260 Process for the preparation of 2,2-dimethyl-5-(2,5-dimethyl-phenoxy)-pentanoic acid, intermediates for preparing this compound and process for preparing the intermediates |
10/13/1992 | US5155259 Aldose reductase inhibitor |
10/13/1992 | US5155250 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
10/13/1992 | US5155249 Differentiating neoplastic cells, treating psoriasis, immune or inflammatory diseases |
10/13/1992 | US5155218 Dna encoding human 5-ht1d receptors |
10/13/1992 | US5155137 Releases nitric oxide(NO) in vivo in a stable controlled fashion; therapy for cardiovascular disorders and hypertension |
10/13/1992 | US5155133 Antiarrhythmic compounds and pharmaceutical compositions and methods thereof |
10/13/1992 | US5155129 Agents for treating disorders from cerebral neuro-degeneration |
10/13/1992 | US5155128 Medicaments for the treatment of cerebral apoplexy |
10/13/1992 | US5155127 N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
10/13/1992 | US5155126 Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists |
10/13/1992 | US5155125 Orally Administering; having an aldose reductase inhibitory activity |
10/13/1992 | US5155123 Pyridine derivatives and pharmaceutical compositions containing them |
10/13/1992 | US5155121 Phenylsulphonamide substituted pyridinealkene- and aminooxyalkanecarboxylic acid derivatives |
10/13/1992 | US5155120 Pharmaceutically acceptable acid addition salts of amlodipine |
10/13/1992 | US5155117 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
10/13/1992 | US5155116 Medicinal oxazolopyridine compounds |